These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12623511)

  • 1. Cytokines and other soluble factors in dialysate -- indicators of altered peritoneal function?
    Martikainen TA; Ekstrand AV; Teppo AM; Honkanen EO; Grönhagen-Riska C
    Scand J Urol Nephrol; 2002; 36(6):450-4. PubMed ID: 12623511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study.
    Martikainen T; Ekstrand A; Honkanen E; Teppo AM; Grönhagen-Riska C
    Scand J Urol Nephrol; 2005; 39(5):410-6. PubMed ID: 16257844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration.
    Yang WS; Tsai TJ; Shih CL; Huang JW; Chuang HF; Chen MH; Fang CC
    Blood Purif; 2009; 28(1):69-74. PubMed ID: 19439926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate leukocytes, sICAM-1, hyaluronan and IL-6: predictors of outcome of peritonitis?
    Martikainen TA; Ekstrand AV; Honkanen EO; Teppo AM; Grönhagen-Riska C
    Blood Purif; 2004; 22(4):360-6. PubMed ID: 15297786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal mesothelial cells produce inflammatory related cytokines.
    Yao V; Platell C; Hall JC
    ANZ J Surg; 2004 Nov; 74(11):997-1002. PubMed ID: 15550091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
    Malik AR; Little MA; Henriksson M; Tam FW; Brown EA
    J Nephrol; 2007; 20(3):340-9. PubMed ID: 17557268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of cytokines in peritoneal dialysis].
    Opatrná S; Topolcan O; Opatrný K
    Vnitr Lek; 2000 Nov; 46(11):794-800. PubMed ID: 15637896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
    Sayarlioglu H; Topal C; Sayarlioglu M; Dulger H; Dogan E; Erkoc R
    Mediators Inflamm; 2004 Apr; 13(2):119-21. PubMed ID: 15203553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.
    Chow KM; Szeto CC; Cheung KK; Leung CB; Wong SS; Law MC; Ho YW; Li PK
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):768-73. PubMed ID: 17699285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis.
    Igarashi Y; Morishita Y; Yoshizawa H; Imai R; Imai T; Hirahara I; Akimoto T; Ookawara S; Ishibashi K; Muto S; Nagata D
    Ren Fail; 2017 Nov; 39(1):392-399. PubMed ID: 28201944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of anti-alphaGalactosyl antibodies predict survival and peritoneal dialysis-related enteric peritonitis rates in patients undergoing renal replacement therapy.
    Fontán MP; Máñez R; Rodríguez-Carmona A; Peteiro J; Martínez V; García-Falcón T; Domenech N
    Am J Kidney Dis; 2006 Dec; 48(6):972-82. PubMed ID: 17162152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques.
    Karaduman M; Sengul A; Oktenli C; Pekel A; Yesilova Z; Musabak U; Sanisoglu SY; Gunay C; Baysan O; Kocar IH; Tatar H; Ozata M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):196-202. PubMed ID: 16430720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?
    Martikainen TA; Teppo AM; Grönhagen-Riska C; Ekstrand AV
    Perit Dial Int; 2005; 25(5):453-60. PubMed ID: 16178478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.